Pamela A. Hay

Senior Vice President, Corporate Development at Dyax Corp.

Location:
55 Network Dr, Burlington, Massachusetts, United States
Company:
Dyax Corp.
HQ Phone:
(617) 225-2500
Wrong Pamela Hay?

Last Updated 6/9/2017

General Information

Employment History

Corporate Counsel  - Biogen Inc

Co-Founder and President  - Visgo

Co-Chief Executive Officer  - Harbour Antibodies BV

Commercial Development  - Abbott

Education

B.A.  - Biology , Cornell University

J.D.  - Biology , University of Wisconsin Law School

Ms Hay  - Dyax Corp.

Ms Hay  - T Cell Sciences and Corporate Counsel

Affiliations

Advisor  - NeuroHealing Pharmaceuticals Inc

Chief Commercial Officer  - Domantis Limited

Partner  - Red Sky Partners, LLC.

Web References  

Team - NeuroHealing Pharmaceuticals Inc.

Pamela Hay, J.D.
Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the company purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.

Read More
NeuroHealing Pharmaceuticals Inc.

Pamela Hay, J.D.
Pamela Hay, J.D. Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the companys purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.

Read More
News & Headlines: Diversys Names Pamela Hay Chief Commercial Officer

2001 NOV 12 - (NewsRx.com & NewsRx.net) -- Diversys Ltd., a protein engineering company, has hired business development executive Pamela Hay as chief commercial officer.
Ms. Hay is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering, and is a prolific negotiator of deals in this sector, according to the company. Ms. Hay has more than 15 years of legal and business development experience with major biotechnology and pharmaceutical companies. With a degree in biology from Cornell and a law degree from the University of Wisconsin. She joined Dyax Corp. in 1996, where she rose to become senior vice president of corporate development and strategic opportunities. Within Dyax, Ms. Hay and her team negotiated over 75 collaboration, technology transfer and license agreements involving the company's phage display technology and product leads, managed the company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies. Ms. Hay will assume responsibility for the commercialization of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use. In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio. Ms. Hay will be based in Diversys' new commercial office in Cambridge, Massachusetts. This article was prepared by Health & Medicine Week editors from staff and other reports.

Read More

Browse ZoomInfo’s Directories